Use of mitoxantrone preparation in preparation of drug for diagnosing and treating breast cancer

A lymphatic tracing method for a disease related to mastectomy, comprising:

• administering a lymphatic tracer intraoperatively to a patient during mastectomy surgery,
• wherein the lymphatic tracer contains mitoxantrone hydrochloride, sodium chloride, acetic acid, sodium acetate, sodium pyrosulfite and sodium sulfate;
• wherein the content of the mitoxantrone hydrochloride is 1-15 mg/mL;
• the content of the sodium chloride is 3-18 mg/mL;
• the content of the acetic acid is 0.15-1 mg/ml;
• the content of the sodium acetate is 0.03-0.15 mg/mL;
• the content of the sodium pyrosulfite is 0.05-0.3 mg/mL;
• and the content of the sodium sulfate is 0.05-0.6 mg/ml,
• wherein the lymphatic tracer is an injection;
• wherein the injection is administered subcutaneously;
• wherein the injection is administered locally;
• wherein the injecting sites are on the breast gland and/or tissues and organs around the breast;
• wherein the injection is administered at multiple sites;
• wherein the concentration of the injection is 2-10 mg/ml;
• and
• wherein the volume of the injection is 0.1-3.0 mL.